Den ene af undersøgelserne omfattede 482 patienter med svær allergisk astma, der ikke kunne kontrolleres med et sædvanligt lægemiddel.
Xolair has been studied in patients with allergic asthma in five main studies involving 2,299 patients, including one study of 482 patients with severe allergic asthma that was not controlled by conventional treatments.